Results 1 to 10 of about 530,938 (302)

Additional file 2: of Clustering of disulfide-rich peptides provides scaffolds for hit discovery by phage display: application to interleukin-23

, 2016
David T. Barkan, Xiaoli Cheng, Herodion Celino, Tran Tran, Ashok Bhandari, Charles S. Craik, Andrej Săli, Mark L. Smythe   +7 more
openalex   +1 more source

Translational Pharmacokinetics of Icotrokinra, a Targeted Oral Peptide that Selectively Blocks Interleukin-23 Receptor and Inhibits Signaling. [PDF]

Dermatol Ther (Heidelb)
Knight B, Tammara B, Modi NB, Dallas S, Mardirosian S, Wang J, Laenen A, Leclercq L, DiLoreto K, Adriaenssen L, Moss D, Polidori D, Chaudhuri SR, Park S, Sensenhauser C, Ndifor A, Sukumaran S, Baguet T, Shi Y, Patel S, Geist B, Fourie A, Patch R, Sun C, Barros SA, Somani S, Monshouwer M.   +26 more
europepmc   +1 more source

Combination of mechanical debridement and interleukin 12 or interleukin 23 therapy for refractory facial pyoderma gangrenosum with NOD2 mutation. [PDF]

JAAD Case Rep
Vague M, Shea M, Thacker S, Onoday H, Ortega Loayza AG.   +4 more
europepmc   +1 more source

Implications for a role of interleukin-23 in the pathogenesis of chronic gastritis and of peptic ulcer disease

, 2008
Vassilios Koussoulas, Spyridon Vassiliou, Evangelos J. Giamarellos‐Bourboulis, Georgios Tassias, Antigone Kotsaki, C. Barbatzas, Michalis Tzivras   +6 more
openalex   +2 more sources

Anti-interleukin-23 treatment linked to improved <i>Clostridioides difficile</i> infection survival. [PDF]

Gut Microbes
Madden GR, Preissner R, Preissner S, Petri WA.   +3 more
europepmc   +1 more source

A case of psoriasis and atopic dermatitis-like rash induced by interleukin-17 and interleukin-23 inhibitors successfully controlled with upadacitinib. [PDF]

JAAD Case Rep
Okazaki T, Takahashi T, Sugiura R, Shimada-Omori R, Asano Y.   +4 more
europepmc   +1 more source

Comparison of the Efficacy of Interleukin-23 Inhibitors in the Treatment of Psoriasis in a Tertiary Care Hospital

JM Vinuesa Hernando
openalex   +1 more source

CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation. [PDF]

Nature
Ahmed A, Joseph AM, Zhou J, Horn V, Uddin J, Lyu M, Goc J, JRI Live Cell Bank, Sockolow RE, Wing JB, Vivier E, Sakaguchi S, Sonnenberg GF.   +12 more
europepmc   +1 more source

The role of interleukin-17 and interleukin-23 inhibitors in the development, progression, and recurrence of cancer: A systematic review. [PDF]

JAAD Int
Vangilbergen M, Stockman A, Van De Velde A, Garmyn M, Punie K, Hillary T.   +5 more
europepmc   +1 more source

Activation of the interleukin-23/Th17 axis in major depression: a systematic review and meta-analysis. [PDF]

Eur Arch Psychiatry Clin Neurosci
Moulton CD, Malys M, Hopkins CWP, Rokakis AS, Young AH, Powell N.   +5 more
europepmc   +1 more source